Person measuring their waist depicting type 2 diabetes treatment

180,000 people to benefit from new type 2 diabetes treatment

Around 180,000 diabetes patients are set to benefit from a new treatment option thanks to a National Institute for Health and Care Excellence (NICE) recommendation.

In final draft guidance published today, NICE proposes those with poorly controlled type 2 diabetes should get treated with tirzepatide, a patient-administered weekly injection. Tirzepatide is manufactured by Eli Lilly and is otherwise known as Mounjaro.

Clinical trial data presented to a NICE committee showed the treatment was much better at reducing blood sugar levels and body weight compared to its alternatives – this includes semaglutide, insulin therapy and a placebo.

Between 81% and 97% of people undergoing treatment with tirzepatide achieved better glucose control, while 54% to 88% reached a 5% or more weight reduction.

                                                                           Video credit: Canva

Over five million people live with diabetes in the UK, according to Diabetes UK. Approximately 90% of those case are type 2 diabetes.

Nearly two in three of these people do not have their type 2 diabetes under control, which can lead to blindness, kidney disease, heart attack or stroke.

Following further cost and clinical analysis, NICE recommended the treatment in conjunction with diet and exercise.

“Poorly controlled type 2 diabetes, with its associated additional health risks, is a huge challenge for those living with the condition and the NHS,” said NICE’s director of medicines evaluation, Helen Knight.

“This recommendation will offer fresh hope for many and provide value for money for the taxpayer.”

Once final guidance is released, which is expected to be 11 October 2023, the product will be available to the NHS within 90 days.

To access the full draft guidance, click here.

Image credit: iStock

Website cover

NHE May/June 2024

Join the conversation shaping the future of healthcare.

Click below to read more!

More articles...

View all
Online Conference

Presenting

2024 Online Conferences

In partnership with our community of health sector leaders responsible for delivering the UK's health strategy across the NHS and the wider health sector, we’ve devised a collaborative calendar of conferences and events for industry leaders to listen, learn and collaborate through engaging and immersive conversation. 

All our conferences are CPD accredited, which means you can gain points to advance your career by attending our online conferences. Also, the contents are available on demand so you can re-watch at your convenience.

National Health Executive Podcast

Listen to industry leaders on everything within healthcare

Whether it's the latest advancements in medical technology, healthcare policies, patient care innovations, or the challenges facing healthcare providers, we cover it all.

 

Join us as we engage with top healthcare professionals, industry leaders, and policy experts to bring you insightful conversations that matter.